Market Overview

Morning Market Losers

Related SNTA
Netflix, Panera Bread Lead Wednesday's After-Hours Movers
Benzinga's Top Initiations
Top 2 Trade Alert Ideas October 7: Spark's Pullback, Synta Catalyst, M&A Activity (Seeking Alpha)
Related INFI
Infinity Announces Enrollment Of 120th Patient In Phase 2 DYNAMO™ Study Evaluating Duvelisib In Indolent Non-Hodgkin Lymphoma
New Biotech Pair Trade: Infinity Pharma Over ImmunoGen
Infinity (INFI) Updates on Duvelisib and IPI-549 on R&D Day (Zacks)

Synta Pharmaceuticals (NASDAQ: SNTA) shares dipped 32.93% to $4.95 after the company reported positive overall survival results from GALAXY-1 Phase 2b/3 trial of ganetespib in second-line non-small cell lung cancer.

Infinity Pharmaceuticals (NASDAQ: INFI) shares lost 23.41% to $20.64 on Phase 1 data.

Affymax (NASDAQ: AFFY) fell 22.60% to $1.61. Affymax's PEG ratio is -0.17.

National Bank of Greece SA (NYSE: NBG) dropped 12.60% to $6.31. The bank's trailing-twelve-month profit margin is -98.37%

Posted-In: Morning Market LosersNews Movers & Shakers Intraday Update Markets


Related Articles (AFFY + INFI)

View Comments and Join the Discussion!

Get Benzinga's Newsletters